Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

NCT04499300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-03-29

No results posted yet for this study

Summary

SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ranging from asymptomatic forms to more commonly critical pulmonary forms called "Acute Respiratory Distress Syndrome". The elderly population is more at risk for this infection due to the senescence of the immune system, co-morbidities and poly medications. They also often present a greater state of fragility.

This study aims to report the epidemiology of the first 50 patients over 90 years of age hospitalized within the CHU Brugmann hospital.

Conditions

  • Covid19

Interventions

OTHER

Data collection from medical files

Data collection from medical files

Sponsors & Collaborators

  • Murielle Surquin

    lead OTHER

Eligibility

Min Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-09
Primary Completion
2020-11-23
Completion
2020-11-23

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04499300 on ClinicalTrials.gov